Scalability
From a single review to global submission support, we scale effortlessly to meet your project needs.
Criterion Edge offers specialized support across the entire CER lifecycle, from clinical evidence strategy and literature evaluation to benefit-risk analysis and notified body submission support. Our services are aligned with EU MDR requirements and applicable guidance to support robust, defensible clinical evaluations.
We deliver efficient, EU MDR-compliant Clinical Evaluation Reports through a transparent, collaborative process designed to satisfy notified body expectations.
We align early on device classification, intended purpose, equivalence approach, and clinical evidence requirements to establish a clear, defensible path to EU MDR alignment. This is captured in your Clinical Evaluation Plan (CEP), which guides the evaluation that follows.
We conduct comprehensive systematic literature reviews and assess all available clinical data including pre-clinical studies, clinical investigations, PMCF data, and vigilance information to build a robust evidence base.
We critically appraise all clinical data sources, establish state of the art benchmarks, and develop structured benefit-risk analyses aligned with MEDDEV 2.7/1 Rev.4 expectations.
We develop a comprehensive CER per Annex XIV requirements, applying rigorous quality, consistency, and traceability reviews to ensure clarity and regulatory defensibility.
We support regulatory review readiness through final CER package preparation, written response development for regulatory questions, and ongoing CER updates across the device lifecycle.
Criterion Edge provides strategic, EU MDR-aligned CER support for medical device manufacturers. Our approach combines regulatory expertise, scientific rigor, and clear documentation to support robust clinical evaluations and informed regulatory review.
Clients are supported by experienced CER writers who lead equivalence assessments, literature review strategy, and benefit-risk analysis, ensuring a focused, defensible approach tailored to each device and its clinical context.
We develop and integrate clinical evidence, literature analysis, and benefit-risk conclusions per MEDDEV 2.7/1 Rev.4 and Annex XIV requirements, ensuring consistency across device description, state of the art analysis, and clinical data appraisal.
Our team synthesizes clinical data, literature findings, and post-market evidence into clear, well-structured CER content, supported by structured quality and consistency reviews to support regulatory review readiness.
We translate complex clinical data into clear, defensible regulatory narratives that support the demonstration of safety and performance and inform benefit-risk conclusions across the device lifecycle.

From initial CE marking through periodic updates and PMCF integration, Criterion Edge supports the development of EU MDR-compliant CERs that demonstrate clinical safety and performance and support regulatory review in Europe.
Your CER deserves more than just a freelancer. At Criterion Edge, each project is staffed with a dedicated, specialized team to ensure speed, consistency, and subject-matter accuracy.

We tap into a distributed team with deep therapeutic and regulatory experience - working around the clock to move your project forward.

You'll work with protocol developers, medical writers, and therapeutic-area experts aligned to your specific evidence needs.

Need to move faster or adjust scope? We scale resources up or down to meet your timeline and budget - without sacrificing quality.
We don't just check boxes - we partner with your team to deliver high-quality, submission-ready results. Here's what sets us apart:
From a single review to global submission support, we scale effortlessly to meet your project needs.
Our team includes seasoned experts across regulatory, clinical, and therapeutic domains.
Built-in quality control ensures every deliverable is compliant, consistent, and audit-ready.
Streamlined workflows and dedicated project teams reduce turnaround time - without cutting corners.
Below are the average scores (out of 5) for each of the criteria we ask our clients to grade us on after every project.



Pharmaceutical and medical device companies face growing pressure to deliver high-quality, compliant evidence on tight timelines - with limited internal resources. Criterion Edge was built to fill that gap with expert-led, scalable CER services.
From MEDDEV 2.7/1 Rev.4 compliance to Annex XIV requirements and evolving Notified Body expectations, CER requirements demand expertise and vigilance. We navigate the pathway to CE marking for you.
Late reports, misaligned expectations, or unclear deliverables waste valuable time. Our team is known for quality, clarity, and on-time delivery.
nternal CER teams can be costly and hard to scale. Outsourcing with us helps you meet your clinical evidence goals while staying within budget.
CER expertise is niche and hard to hire. Our experienced writers and reviewers are ready to support your projects right now.

With over two decades in the pharmaceutical and medical device sectors, Laurie Mitchell saw firsthand how regulatory and clinical teams struggled with evidence synthesis. She launched Criterion Edge to deliver high-quality CERs that close the gap between complex scientific literature and actionable submission-ready reports.
Under her leadership, Criterion Edge has supported top global brands across regulatory submissions, clinical strategy, and market access for providing expert-written, fully documented CER’s trusted by teams around the world.
Let’s discuss your Clinical Evaluation Report needs and how Criterion Edge can support your strategic objectives.”